Growing use of paracetamol as an analgesic and antipyretic agent is expected to drive the growth of India paracetamol market.
According to TechSci Research report, “India Paracetamol Market By Source (In-house v/s Contract Manufacturing Organizations), By Product (Powder v/s Granules), By Form (Tablet, Capsules, Oral Solution), By Route of Administration (Oral v/s Intravenous), By Distribution Channel (Online v/s Offline), By Application (Pain & Fever Reliver, Muscle Cramps, Cold & Cough, Others), By End User (Adult v/s Pediatric), By Company, By Region, Forecast & Opportunities, FY2026”, the India paracetamol market is expected to grow at an impressive rate during the forecast period on account of the growing awareness among the consumers pertaining to pain management. Additionally, paracetamol is used as an active pharmaceutical ingredient (API) for manufacturing several generic and OTC drugs. This is expected to positively influence the market growth through FY2026. Furthermore, the widespread use of paracetamol in treating a range of conditions including headache, muscle pain, fever, arthritis, cold and cough, backache, toothache, among others is further expected to fuel the market growth over the next few years. This in turn has led to an increase in demand and consumer preference for paracetamol as an over the counter medication. However, side-effects such as loss of appetite, stomach pain and low fever with nausea can hamper the market growth over the next five years. Moreover, in several cases serious side-effects in the form of jaundice can be observed. Also, in case of chronically alcoholic patients and those suffering from liver diseases the use of paracetamol should be avoided. This further slows down the market growth through FY2026.
Browse XX market data Tables and XX Figures spread through XX Pages and an in-depth TOC on“ India paracetamol market “
https://www.techsciresearch.com/report/india-paracetamol-market/5139.html
The India paracetamol market is segmented based on source, product, form, route of administration, distribution channel, application, end user, company and region. Based on form, the market can be fragmented into tablet, capsule and oral solution. The tablet segment is expected to dominate the market during forecast period. This can be attributed to the associated benefits such as safety, efficacy in delivering oral medications, low cost, easy availability, among others. On the other hand, capsules have higher drug absorption and are fast acting. Also, they are tampering resistant and tasteless. Based on route of administration, the market can be split into oral and intravenous. The intravenous route of administration is expected to hold a significant market share owing to its 100% bioavailability and ability to administer a large dose of a drug. Additionally, this route of administration is helpful in case of drugs that are not absorbed orally. Based on distribution channel, the market can be split into online and offline. The offline segment is expected to dominate the market through FY2026. This can be ascribed to the widespread network of pharmacies and drug stores where the drug is easily available both as a prescription medicine and as an OTC drug.
GlaxoSmithKline Pharmaceuticals Ltd., Granules India Limited, Farmson Pharmaceutical Gujarat Private Limited, Sun Pharmaceutical Industries Ltd., Dr. Reddy’s Laboratories, CFL Pharmaceuticals Limited, Cipla Limited, Sanofi India Limited, Sri Krishna Pharmaceuticals Limited, Vaishali Pharma Limited and others are some of the leading players operating in India paracetamol market. Companies operating in the market are using organic strategies such as product launches, mergers and collaborations to boost their share.
Download Sample Report @ https://www.techsciresearch.com/sample-report.aspx?cid=5139
Customers can also request for 10% free customization on this report.
“India paracetamol market is expected to witness growth during the forecast period on account of the growing demand for pain management drug solutions. Additionally, the growing prevalence of conditions like flu, fever, headache, among others are further expected to positively influence the market growth. Besides, the versatility, brand value and consumer faith on the medication are further expected to spur the market growth over the next few years.” said Mr. Karan Chechi, Research Director with TechSci Research, a research based India management consulting firm.
“India Paracetamol Market By Source (In-house v/s Contract Manufacturing Organizations), By Product (Powder v/s Granules), By Form (Tablet, Capsules, Oral Solution), By Route of Administration (Oral v/s Intravenous), By Distribution Channel (Online v/s Offline), By Application (Pain & Fever Reliver, Muscle Cramps, Cold & Cough, Others), By End User (Adult v/s Pediatric), By Company, By Region, Forecast & Opportunities, FY2026”, has evaluated the future growth potential of India paracetamol market and provides statistics & information on market size, structure and future market growth. The report intends to provide cutting-edge market intelligence and help decision makers take sound investment decisions. Besides, the report also identifies and analyzes the emerging trends along with essential drivers, challenges and opportunities in India paracetamol market.
Contact
Mr. Ken Mathews
708 Third Avenue,
Manhattan, NY,
New York – 10017
Tel: +1-646-360-1656
Email: [email protected]